Basics Anika Therapeutics Inc. Anika Therapeutics Inc develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. IPO Date: January 3, 1994 Sector: Healthcare Industry: Biotech Market Cap: $138.44M Activated in VL: True Average Daily Range Avg Daily Range: $0.43 | 1.98% Avg Daily Range (30 D): $0.16 | 1.64% Avg Daily Range (90 D): $0.21 | 2.22% Institutional Daily Volume Avg Daily Volume: .1M Avg Daily Volume (30 D): .13M Avg Daily Volume (90 D): .11M Trade Size Avg Trade Size (Sh.): 99 Avg Trade Size (Sh.) (30 D): 61 Avg Trade Size (Sh.) (90 D): 58 Institutional Trades Total Inst.Trades: 1,259 Avg Inst. Trade: $1.25M Avg Inst. Trade (30 D): $1.1M Avg Inst. Trade (90 D): $1.1M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.19M Avg Closing Trade (30 D): $.67M Avg Closing Trade (90 D): $.67M Avg Closing Volume: 33.19K     News Dec 6, 2025 @ 1:00 AM Anika Therapeutics, Inc. INVESTIGATION: Kirby McIn... Source: Kirby Mcinerney Llp Sep 25, 2025 @ 9:43 PM ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. is... Source: Bragar Eagel & Squire, P.C. Sep 5, 2025 @ 9:00 AM Anika Reports Inducement Grants Under Nasdaq Listi... Source: Anika Therapeutics, Inc. Aug 17, 2025 @ 3:00 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Danielle Peyton Aug 12, 2025 @ 11:34 PM ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. Co... Source: Bragar Eagel & Squire, P.C. Financials   TTM Q3 2025 Q2 2025 Basic EPS $-2.27 $-.16 $-.28 Diluted EPS $-2.27 $-.16 $-.28 Revenue $ 112.81M $ 27.82M $ 28.22M Gross Profit $ 61.75M $ 15.58M $ 14.36M Net Income / Loss $ -33.04M $ -2.33M $ -3.97M Operating Income / Loss $ -12.4M $ -3.23M $ -4.18M Cost of Revenue $ 51.05M $ 12.23M $ 13.86M Net Cash Flow $ -4.4M $ 5.13M $ -.55M PE Ratio